
How One Small Biotech Protected (And Grew) Share Against A 3× Larger Competitor
When a better-funded rival comes in with three times your field force, “work harder” isn’t a strategy. In pharma sales, access is tighter, prior auth eats your day, and HCPs...
Read More →